-
Targeted vs. Nontargeted HIV Screening: The Debate Continues
Opt-out HIV testing in all healthcare settings is recommended, but the effectiveness remains controversial.
November 28, 2011
-
HIV/TB Coinfection + Low CD4-Cell Count = Start ART Sooner Rather Than Later
What is the optimal timing of early ART initiation in HIV/TB-coinfected patients?
November 15, 2011
-
Once-Daily Nevirapine Inferior to Efavirenz in HIV/TB-Coinfected Patients
Nevirapine has been considered an acceptable alternative to Efavirenz for HIV/TB infected patients, but a recent study shows it is an inferior treatment.
October 31, 2011
-
The Success of Antiretroviral Therapy: No Time to Rest
How successful is antiretroviral therapy in an inner city population?
October 17, 2011
-
Dolutegravir Dosage Considerations for Patients Taking Etravirine
Coadministering etravirine and dolutegravir results in substantially decreased levels of dolutegravir. How do we restore the pharmacokinetics?
September 28, 2011
-
Incidence and Characteristics of HIV Infection in the U.S.
The number of new HIV infections in the U.S. remains unacceptably high, despite ongoing prevention efforts.
September 14, 2011
-
Viral-Load Monitoring Beneficial in Resource-Constrained Settings
Although viral load monitoring is beneficial in resource-constrained settings, increasing the monitoring for patients on ART will decrease the funds available to provide ART to more patients.
August 25, 2011
-
Treatment is Prevention: The Results of HPTN 052
Treatment of HIV infection decreases the risk for sexual transmission and improves the lives of those infected.
August 11, 2011
-
Abacavir and Cardiovascular Risk: Still No Clarity
Is Abacavir associated with an increased risk for cardiovascular disease in HIV infected patients?
July 28, 2011
-
Immediate ART of No Benefit in Patients With Tuberculous Meningitis
How important is the timing of ART therapy for HIV infected patients with tuberculosis? The results may surprise you.
July 14, 2011
-
When to Start ART, Take 3
When is the best time to begin antiretroviral therapy in HIV-infected patients?
June 23, 2011
-
Low-Frequency Drug-Resistance Mutations and ART Failure
How common is drug resistance in NNRTI-based antiretroviral therapy?
June 16, 2011
-
Is It Time for a Second One-Pill Once-Daily Regimen?
Is one-pill once-daily still the preferred method of administering antiretroviral therapy?
May 19, 2011
-
Waiting to Start ART in These Patients? Think Again.
How quickly should antiretroviral therapy be started in HIV patients? This study looks specifically at patients who have recently seroconverted.
May 12, 2011
-
Once-Daily Darunavir in Treatment-Experienced Patients: ODIN Results Published
Is dosing important in antiretroviral therapy? Is once a day enough?
May 02, 2011
-
Efavirenz vs. Boosted Atazanavir in ACTG 5202
This article reviews some of the differences in initial therapies for HIV infection.
April 25, 2011
-
HCV Infection in HIV-Positive MSM
How important is it to test HIV positive gay men for hepatitis C?
April 18, 2011
-
What's the Best Way to Measure ART Adherence?
How can healthcare providers properly and efficiently measure adherence with antiretroviral therapy in HIV infected patients?
April 04, 2011
-
Few New AIDS Events Despite Incomplete Immune Recovery
Does success with antiretroviral therapy predict future AIDS related illnesses?
February 20, 2011
-
Curing HIV?
Is it possible to completely cure HIV? This short report takes a look at one patient's experience.
February 14, 2011
